If management are working in the interest of shareholders, I wonder what the next move would be. Progress with EMA approved phase III trial or continue trying to harmonise studies leading to delay of progress and likely reduction of SP.
The shorter term part of me hopes progress with EMA trial and stop the share price bleeding and continue discussions with FDA in parallel. Partner with big pharma with EMA progress/results then head to the FDA with a big tailwind. An answer by mid July I would expect.
- Forums
- ASX - By Stock
- IXC
- Ann: Investor Presentation
Ann: Investor Presentation, page-14
-
-
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.2¢ |
Change
0.002(2.86%) |
Mkt cap ! $5.411M |
Open | High | Low | Value | Volume |
7.2¢ | 7.2¢ | 7.2¢ | $1.701K | 23.62K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 76375 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 76375 | 0.072 |
1 | 52915 | 0.070 |
1 | 84879 | 0.067 |
1 | 100000 | 0.066 |
1 | 50000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 5000 | 1 |
0.085 | 8805 | 1 |
0.090 | 126146 | 1 |
0.095 | 100000 | 1 |
0.100 | 8505 | 2 |
Last trade - 15.42pm 13/09/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online